Clinical Trial Update: A Dose-finding Phase IIb Study With AZD0865 and Esomeprazole in GERD Patients With Erosive Esophagitis. [Phase 2]

View source ↗

Summary

A Phase 2b dose-finding trial of AZD0865 with esomeprazole in gastroesophageal reflux disease with erosive esophagitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erosive Esophagitis
• Gastroesophageal Reflux Disease

Drugs mentioned

• AZD0865
• Esomeprazole (Esomeprazole)

Snippet

Sponsor: AstraZeneca | Conditions: GERD With Erosive Esophagitis | Phase 2 | Status: COMPLETED